BioSpace News Archive

Business

Advaxis Reports Fiscal Year 2018 Financial Results and Provides a Business Update

Advaxis, Inc. (NASDAQ: ADXS) (the Company), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces its financial results for the fiscal year ended October 31, 2018 and provides a business update.

January 10, 2019
·
8 min read
Business

Universal Health Services, Inc. Announces Date For 2018 Fourth Quarter And Full Year Earnings Release And Conference Call

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its 2018 fourth quarter and full year ended December 31, 2018 after the market closes on Wednesday, February 27, 2019.

January 10, 2019
·
1 min read
Biotech Beach

Soberlink Introduces Advanced Reporting

Today, Soberlink, the leader in remote alcohol monitoring technology, announced Advanced Reporting, the first use of data analysis to display alcohol monitoring results.

January 10, 2019
·
3 min read
Policy

Perflow Medical Expands IP Coverage for Novel Stream™ Dynamic Neuro-Thrombectomy Net Device and Cascade™ Non-Occlusive Remodeling Net

Clinical data to be presented at 2019 ABC-WIN Seminar

January 10, 2019
·
2 min read
First Patient in the United States Successfully Treated With IRRAflow®

- US Launch on Track -

January 10, 2019
·
3 min read
Biotech Bay

Gynesonics Announces Publication of Final SONATA IDE Pivotal Trial Results in the Journal, Obstetrics and Gynecology

Robust Outcomes Support the Potential of the Sonata System as a First-Line Treatment for Symptomatic Uterine Fibroids

January 10, 2019
·
5 min read
Drug Development

Acceleron Announces Publication of Luspatercept Phase 2 Beta-Thalassemia Study Results in Blood

Acceleron Pharma Inc. today announced that the journal Blood has published results from the Phase 2 study of luspatercept in patients with red blood cell (RBC) transfusion-dependent and non-transfusion-dependent beta-thalassemia.

January 10, 2019
·
6 min read
Deals

genae Buys MedicSense

genae, Experts in Value-driven Science & Technology for the Medical Industries, today announced the acquisition of MedicSense, a Clinical, Regulatory Affairs and Quality Assurance consultancy firm

January 10, 2019
·
1 min read
Deals

Premier Health Signs Definitive Agreement for Acquisition of Cloud Practice Inc., a National Medical Software Application Company

Premier Health Group Inc. (CSE: PHGI) (OTCQB: PHGRF) (Frankfurt: 6PH) (the “Company” or “Premier Health”), is pleased to announce, further to its news release dated December 17, 2018, the Company has signed a Definitive Agreement (“the Agreement”) to acquire all of the outstanding securities of Cloud Practice Inc. (“Cloud Practice”).

January 10, 2019
·
5 min read
Business

GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology

GigaGen Inc., a biopharmaceutical company developing novel antibody therapies, today announced that Erica Stone, Ph.D., has joined the company as director, immuno-oncology.

January 10, 2019
·
2 min read